ABBV

AbbVie operates as a research-based biopharmaceutical company, functioning as a significant entity within the global healthcare sector. Originally spun off from Abbott Laboratories, the company has established a distinct identity focused on specialized therapeutic areas, including immunology, oncology, neuroscience, and aesthetics. Its market role is defined by a portfolio that balances high-volume specialty drugs with a robust pipeline of experimental treatments. As a constituent of major equity indices, AbbVie is often monitored by institutional investors for its role in the defensive healthcare sector, which is frequently sought after for its potential stability and dividend history during periods of broader economic uncertainty.